Corbus Pharmaceuticals (CRBP) Q3 2024 Earnings

Aug 6Confirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-2.27
-1.79
-1.31
-0.83

Details

Expected EPS
-1.187967
Actual EPS
-0.9
Surprise EPS
0.29
Surprise Percent
+24.24%

Description

⁨Corbus Pharmaceuticals⁩ (⁦CRBP⁩) has reported earnings of ⁦-0.9⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts